Literature DB >> 18272867

Evidence of thalamic gray matter loss in pediatric multiple sclerosis.

S Mesaros1, M A Rocca, M Absinta, A Ghezzi, N Milani, L Moiola, P Veggiotti, G Comi, M Filippi.   

Abstract

OBJECTIVE: We used voxel-based morphometry (VBM) to assess the pattern of regional gray matter (GM) loss in patients with pediatric multiple sclerosis (MS) and its relation with the Expanded Disability Status Scale (EDSS) score, disease duration, and the extent of T2 lesion load (LL).
METHODS: From 28 patients with pediatric relapsing-remitting MS (16 girls; mean age = 14.4 years, range = 7 to 16 years) and 21 matched controls, dual-echo and three-dimensional T1-weighted magnetization prepared rapid acquisition gradient echo sequences were acquired. T2 LL was measured using a local thresholding segmentation technique. Data were analyzed using an optimized VBM analysis and statistical parametric mapping.
RESULTS: In pediatric patients with MS, mean brain T2 LL was 7.8 mL +/- 11.3. Intracranial volume did not differ between patients and controls. Compared to controls, patients with pediatric MS had significant GM loss in the thalamus, bilaterally, which was significantly correlated with T2 LL (r = -0.80 for the right thalamus, r = -0.74 for the left thalamus, p < 0.05, corrected for multiple comparisons). No correlation was found between thalamic GM loss, disease duration, and disability.
CONCLUSIONS: In patients with pediatric multiple sclerosis (MS), differently from what happens in adult-onset MS, gray matter (GM) atrophy seems to involve the thalamus only, with sparing of the cortex and other deep GM nuclei. The correlation found between atrophy and T2 lesion load suggests transsynaptic and Wallerian degenerations as the most likely substrate of tissue loss in the thalamus of these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18272867     DOI: 10.1212/01.wnl.0000291010.54692.85

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Diffusion tensor-MRI evidence for extra-axonal neuronal degeneration in caudate and thalamic nuclei of patients with multiple sclerosis.

Authors:  S Hannoun; F Durand-Dubief; C Confavreux; D Ibarrola; N Streichenberger; F Cotton; C R G Guttmann; D Sappey-Marinier
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

2.  Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution.

Authors:  A Martin; C Sevin; C Lazarus; C Bellesme; P Aubourg; C Adamsbaum
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

3.  Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?

Authors:  Maria A Rocca; Martina Absinta; Angelo Ghezzi; Lucia Moiola; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 4.  MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

Authors:  Massimo Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

5.  Hypothalamus syndrome in opticospinal multiple sclerosis.

Authors:  Y Zhang; R Dong; H Fan; S Li; D Geng
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

6.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

7.  MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.

Authors:  Antonio Cerasa; Paola Valentino; Carmelina Chiriaco; Domenico Pirritano; Rita Nisticò; Cecilia M Gioia; Maria Trotta; Francesco Del Giudice; Tiziana Tallarico; Federico Rocca; Antonio Augimeri; Giacinta Bilotti; Aldo Quattrone
Journal:  J Neurol       Date:  2012-12-28       Impact factor: 4.849

8.  A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.

Authors:  Antonia Ceccarelli; Maria A Rocca; Paola Valsasina; Mariaemma Rodegher; Elisabetta Pagani; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

9.  Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.

Authors:  Kedar R Mahajan; Kunio Nakamura; Jeffrey A Cohen; Bruce D Trapp; Daniel Ontaneda
Journal:  Ann Neurol       Date:  2020-05-01       Impact factor: 10.422

Review 10.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.